Literature DB >> 11038377

The antigenic domain 1 of human cytomegalovirus glycoprotein B contains an intramolecular disulphide bond.

Andrea Speckner1, Barbara Kropff1, Susanne Knör1, Michael Mach1.   

Abstract

Glycoprotein B (gB, gpUL55) is the major antigen recognized by the neutralizing humoral immune response against human cytomegalovirus (HCMV). The immunodominant region on gB is the antigenic domain 1 (AD-1), a complex structure that requires a minimal continuous sequence of more than 75 amino acids (aa 552-635) for antibody binding. In this study, the structural requirements for antibody binding to AD-1 have been determined. The domain was expressed in prokaryotic and eukaryotic systems and analysed in immunoblots under reducing and non-reducing conditions. In addition, AD-1 was purified in an immunologically active form and the concentration of sulphydryl groups was determined. The data clearly show that the only form that is recognized by antibodies is a disulphide-linked monomer of AD-1. The disulphide bond is formed between cysteines at amino acid positions 573 and 610 of gB.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11038377     DOI: 10.1099/0022-1317-81-11-2659

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  5 in total

1.  Identification and expression of immunogenic proteins of a disease-associated marine turtle herpesvirus.

Authors:  Sadie S Coberley; Richard C Condit; Lawrence H Herbst; Paul A Klein
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

2.  Antigenic domain 1 is required for oligomerization of human cytomegalovirus glycoprotein B.

Authors:  William J Britt; Michael A Jarvis; Derek D Drummond; Michael Mach
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

3.  Analysis of Epstein-Barr virus glycoprotein B functional domains via linker insertion mutagenesis.

Authors:  Jessica J Reimer; Marija Backovic; Charuhas G Deshpande; Theodore Jardetzky; Richard Longnecker
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

4.  Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusion.

Authors:  Xiao Zhang; Junping Hong; Ling Zhong; Qian Wu; Shanshan Zhang; Qianying Zhu; Haiwen Chen; Dongmei Wei; Rui Li; Wanlin Zhang; Xinyu Zhang; Guosong Wang; Xiang Zhou; Junyu Chen; Yinfeng Kang; Zhenghui Zha; Xiaobing Duan; Yang Huang; Cong Sun; Xiangwei Kong; Yan Zhou; Yanhong Chen; Xiaoping Ye; Qisheng Feng; Shaowei Li; Tong Xiang; Song Gao; Mu-Sheng Zeng; Qingbing Zheng; Yixin Chen; Yi-Xin Zeng; Ningshao Xia; Miao Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-02       Impact factor: 12.779

5.  A gB/CD3 bispecific BiTE antibody construct for targeting Human Cytomegalovirus-infected cells.

Authors:  Charlotte U Brey; Julia Proff; Natascha Teufert; Benjamin Salzer; Johannes Brozy; Markus Münz; Jochen Pendzialek; Armin Ensser; Wolfgang Holter; Manfred Lehner
Journal:  Sci Rep       Date:  2018-11-28       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.